FDA Inspection 1053519 — Boehringer Ingelheim Pharma GmbH & Co. KG
The FDA completed an inspection of Boehringer Ingelheim Pharma GmbH & Co. KG on May 4, 2018 in Ingelheim am Rhein. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- May 4, 2018
- Fiscal Year
- 2018
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Ingelheim am Rhein (Germany)